09 Jul Disruptive Technologies Redefining the Path of Clinical Trials

By Deepika Khedekar, ACRP

This article delves into the critical role of clinical trials in combating major health crises. It elucidates the multifaceted challenges impeding clinical trials, including patient recruitment, funding, and data management issues, while also highlighting the transformative potential of emerging technologies such as artificial intelligence (AI), blockchain, and genomic sequencing. Specifically, it examines the impact of AI in enhancing trial data analysis and patient recruitment rates, the pivotal role of blockchain in securing data integrity, the dynamic use of wearable devices for continuous patient monitoring, and the cutting-edge application of genomic sequencing in personalized medicine. Furthermore, it addresses the inherent challenges these technologies pose, including data bias, security concerns, and the need for regulatory compliance. Ultimately, the article underscores a hopeful yet cautious outlook towards leveraging these innovations to advance clinical research, emphasizing the importance of ethical considerations and patient-centric approaches in navigating the future of clinical trials. Read more…